Table 5.
PPI group | Vonoprazan group | P value | ||
ITT analysis | 91.5% (292/319) | 89.6% (43/48) | 0.59 | |
Chronic gastritis | ||||
PP analysis | 93.9% (292/311) | 100% (43/43) | 0.15 | |
ITT analysis | 86.4% (38/44) | 100% (8/8) | 0.57 | |
Peptic ulcer | ||||
PP analysis | 95.0% (38/40) | 100% (8/8) | 1 | |
ITT analysis | 78.6% (22/28) | 80% (8/10) | 1 | |
After endoscopic therapy for early gastric cancer | ||||
PP analysis | 78.6% (22/28) | 80% (8/10) | 1 |
PPI: Proton pump inhibitor.